Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXC6MV
|
||||
| Drug Name |
[3-(5-Fluoro-1H-indol-3-yl)-propyl]-[2-(quinoxalin-5-yloxy)-ethyl]-amine
|
||||
| Synonyms |
CHEMBL125902
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C21H21FN4O
|
||||
| Canonical SMILES |
Fc1ccc2[nH]cc(CCCNCCOc3cccc4nccnc34)c2c1
|
||||
| InChI |
InChI=1S/C21H21FN4O/c22-16-6-7-18-17(13-16)15(14-26-18)3-2-8-23-11-12-27-20-5-1-4-19-21(20)25-10-9-24-19/h1,4-7,9-10,13-14,23,26H,2-3,8,11-12H2
|
||||
| InChIKey |
VWAVMVBNSJOHSA-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.